BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration

NCT02062684 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

IgA Nephropathy

Interventions

DRUG: Blisibimod
DRUG: Placebo

Sponsor

Anthera Pharmaceuticals